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Our ethnopharmacological studies, in several Angolan regions, showed that Cymbopogon citratus (DC) Stapf., it´s applied 
in folk medicine to treat several diseases In order to validate antibacterial activity several studies were performed using 12 
bacterial strains. The essencial oil samples of Cymbopogon citratus, obtained by hydro-distillation, were analysed by GC 
and GC-MS. Constituents were identified [1] and tested for their antimicrobial activity by the disc agar diffusion technique 
and the dilution technique against Staphylococcus aureus (ATCC 25923) and Staphylococcus epidermidis (ATCC 12228) 
and other bacterial strains. Broad spectrum antibacterial activity was exhibited by the Cymbopogon citratus essential oil 
against both Gram-positive and Gram-negative bacteria as well as for MRSA that exhibited more sensitive towards the test 
substance compared to the non-MRSA. Our work was the first to show that Cymbopogon citratus essential oil has higher 
antibacterial activity against MRSA strains, than commercial antibiotics. These discover opens a new hope to fight against 
nosocomial infection. 
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1. Introduction 
The indiscriminate use of antimicrobial agents resulted in the emergence of drug-resistant bacteria, fungi and viruses. 
Various populations in developing countries are using medicinal plants against infectious diseases by accidental 
discovery, and trust in the benefit of their use. To overcome the increased resistance of pathogenic microbes, 
researchers are using traditional knowledge as source of development of new drugs with high antimicrobiotic potential. 
The use of phytochemicals as natural antimicrobial agents, commonly called “biocides”, is gaining popularity. There is 
a growing interest among the medical proprieties of medicinal plants in terms of antibacterial activity. Several 
compounds in the essential oil of plants have been recognized for many years as having antibacterial proprieties [2] and 
their preparations have found applications as naturally antimicrobial agents in several fields. 
 In the ongoing search for better antibacterial compounds, plant-derived products are gaining ground [3,4]. Essential 
oils, plant extracts prepared by distillation, are composed by a huge diversity of small hydrophobic molecules, most of 
them accomplishing theoretical criteria of druglike prediction [5]. Such molecules easily diffuse across cell membranes, 
and consequently gain advantage in what concerns interactions with intracellular targets, this being a valuable research 
option in the search of anti-bacterial leads and drugs [6]. C. citratus (DC) Stapf, Family Poaceae, is a widely used herb 
in tropical countries viz. Southeast Asia, Africa and South America and is also known as a source of ethno medicines. 
C. citratus is commonly used in folk medicine in Angola for the treatment of gastrointestinal disturbances, and as an 
antispasmodic, anti-inflammatory, anti-pyretic, and diuretic treatment. Some studies have demonstrated its 
antimicrobial activity, specifically antibacterial, antifungal, and antiprotozoal properties; On the other hand, many 
aromatic plants are today considered as the most important sources for extraction of compounds with strong antioxidant 
activity. Numerous studies have focused on the various biological activities of the secondary metabolites of several 
aromatic species, indicating that several aromatic plants have antioxidant activity. In addition, aromatic plants are 
gaining the interest of pharmaceutical companies for their high potential as antioxidant, these being Rosemary, the first 
spice commercially available for the use as an antioxidant in Europe and USA, marked in an oil soluble form, in dry 
powder and also in water soluble formulations [7]. 
2. Antibacterial Activity of Angolan Cymbopogon Citraus essential oil 
Infectious diseases are responsible for 14 million global deaths annually [8] amongst them bacterial infections being a 
major threat [9]. The only solution to the problem being the use of antibiotics or chemicals. However, the increasing 
failure of chemotherapy and antibiotic resistance exhibited by bacterial pathogens have prompted researchers to screen 
plants for their antimicrobial activity. 
 Angolan folk medicine is rich in plants with antibacterial activity. This activity the result of centuries of trials and 
error experiments. Angolan folk medicine also displays a remarkable potential of bioactive compounds. Various studies 
have revealed the activity of Angolan medical plants in human, animal and plant pathogens, however, very few 







snapshots are available on their antibacterial activity. This chapter discusses the antibacterial activity of Cymbopongus 
Citratus leaves extracts in S aureus, S. epidermidis, E. colli, K. pneumoniae and P. mirabillis, as well as multi-resistant 
drug strains. 
 Although, some studies have demonstrated that several constituents of essential oils have antibacterial activities [10], 
the antibacterial mechanism thereof is still unknown. We considered the possibility that permeabilization of bacterial 
cells’ plasmatic membrane will be the major mechanism for bacterial death. In supported of this hypothesis, our results 
indicate that the composition of the essential oil of Cymbopungus citratus reveal the presence of several hydrophobic 
compounds. Permeabilization studies, using ethidium bromide as a fluorescent probe, were performed in order to 
validate these hypotheses, as described by Sato et all. [11]. 
2.1. Ethno Pharmacological Studies 
The ethno pharmacological study performed in Angola reveal that shrubs are the plants more often used in folk 
medicine. These are followed by trees, the herbaceous and / or subshrubs and vines. Ten (10) of these are included in 
plant families such as: Anacardiaceae, Apocynaceae, Araceae, Capparaceae, Convolvulaceae, Cucurbitaceae, 
Menispermaceae, Nyctaginaceae, Polygalaceae, Rhamnaceae, Rubiaceae, Sapindaceae and Vitaceae. Although the 
leaves and roots are the organs most frequently used in the preparation of medicines, there are cases in which the stem 
bark is more important. In general, the medicines used results from decocting, soaking and spraying of these parts of the 
plants. Our results showed that usually the leaves are used fresh often than dried. 
In addition, our results indicate that respiratory diseases, skin diseases, sexual diseases, malaria and diarrheal diseases 
are most often treated with ethno-pharmacs. Plants like Omundeo (Diplorhynchos condilocarpon (Müll. Arg.) Pichon), 
are used to treat malaria, while species from Rhus family, are indicated for antidiarrheal treatments, especially in cases 
of dysentery. 
 Of all the species identified, “Caxinde tea” (Cymbopongun citratus) is used in treatment of a greater range of 
diseases such as gastrointestinal, antispasmodic, anti-inflammatory, anti-pyretic, and diuretic disturbances. Some 
studies have demonstrated its antimicrobial activity, namely antibacterial, antifungal, and antiprotozoal properties [12-
14]. 
2.2. Antibacterial studies 
Analyses carried out by gas chromatography (GC) and by gas chromatography-mass spectroscopy (GC/MS) allowed 
the identification of compounds in the essential oil of Cymbopogon citratus, the retention time thereof, and its relative 
proportions. The main compounds from C. citratus is geranial (48.4%), neral (32.6%) and myrcene (6.4%) (Pires, 
2012). 
 The results in Table I show that the essential oil concentrations between 15 and 80% inhibit the growth of both S. 
aureus and S. epidermidis, with diameters ranging from 8 to 37 mm in diameter,  
The inhibition of the positive controls ranging from 20.6 to 42.2 mm, corresponding to methacycline 5μg and Penicillin 
G 10mg. 
 The results of inhibition formed by disk diffusion method of essential oil of Cymbopogon citratus on Escherichia 
coli, Klebsiella pneumoniae and Proteus mirabilis (Table I) demonstrate that concentrations of 5 and 20% has no effect 
on the three species tested, and that the maximum effect is obtained when using a figure of 60 to 100%. It should be 
noted that the halos obtained from the essential oil are always lower than those obtained for the positive controls. 
Similar studies were carried out, using the majority constituents present in the essential oil of Cymbopogon citratus. The 
results show that citral at low concentrations has no inhibitory activity on the growth of S. aureus. The dilutions 
between 20 and 45% S. aureus revealed to have only intermediate susceptibility, whereas at concentrations of 60 to 
100% its activity is close to that obtained in positive controls. The same is observed for S. epidermidis, however above 
45% its activity is higher than that obtained with the positive controls, although the difference was not statistically 



















































essential oil (%)   
   
5 9,8 ±1,9 11,2±1,2 0 0 0 
20 16,9 ±1,6 15,4±1,0 0 8,3±0,9 7,3±0,5 
45 18,4±1,5 17,4±1,0 8,7±0,5 10,3±0,5 9,0±0,1 
60 22,3±2,8 22,5±1,8 10,7±0,5 10,0±0,1 9,7±0,5 
80 37,0±2,3 36,0±1,0 10,3±0,5 10,7±0,5 10,0±0,1 
100 24,0±0,7 35,5±1,9 11,3±0,5 10,3±0,5 10,0±0,8 
DMSO 0 0 0 0 0 
Antibiotics    
Mt5 25,8±0,8 26,8±5,4    
PG10 42,2±1,2 20,6±5,7    
AUG30 34,0±0,5 32,5±3,6    
CIP5 28,7±1,2 33,7±0,5 34,0±0,8 
NI300 22,3±1,2 17,7±1,2 10,3±1,2 
CF30 25,3±1,2 19,3±1,2 20,3±1,2 
GM10   18,3±1,2 24,3±1,2 31,0±1,6 
ATCC - American Type Culture Collection; S. aureus - Staphylococcus aureus, S. epidermidis - Staphylococcus epidermidis; E. coli 
- Esherichia coli, K. pneumoniae - Klebsiella pneumoniae, P. Mirabilis - Proteus mirabilis; DMSO - dimethyl sulfoxide; CF 5 – 
Ceftazidima 30μg; 5 CIP-Ciprofloxacin 5μg, NI 300 - 300μg Nitrofurantoin, GM 10 - Gentamicin 10mg., Mt 5 - Metilicin 5μg, PG 
10 - 10mg Penicillin G, Aug 30 - 30μg Augmentin. Sensitivity value: <8mm - Resistant; 9-14mm - Intermediate, 15-19mm - 
Sensitive;> 20mm - Very sensitive. # Values represent means ± standard deviation obtained from three determinations of inhibition 
zones. 
2.3. Antibacterial studies on MRSA strains 
The most important results were obtained when anti-bacterial activity of essential oil of Cymbopogon citratus where 
tested against Methicillin-resistant Staphylococcus aureus (MRSA). 
 
 
Fig. 1 Halos inhibition (mm) of different concentrations of essential oil of Cymbopogon citratus on meticilin resistant S. aureus, as 
compared to a positive control (augmentim AUG-30 PG-10 penicillin and methicillin-MT 5;. NS - not significant. *** statistical 
significance. 
 
 As shown in figure 1, the hospital S. aureus is resistant to the combination amoxicillin / clauvulamic acid 
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Using the essential oil of Cymbopogon citratus at concentrations of 5%, we obtained an inhibitory halo similar to the 
one obtained when using methicillin, penicillin or Augmentin G, however, no statistically significant difference is 
observed (p <0.001). In all other concentrations used, the essential oil achieved a higher inhibitory effect (halo gave a 
major) with statistical significance (p <0.001) compared to the reference of the various antibiotics used in this study. 
Hospital strains of S. epidermidis demonstrate resistance to vancomycin. The results obtained after incubation of S. 
epidermidis showed that essential oil promotes a significantly bigger halo at the concentration of 15% (p <0.001) when 
compared with penicillin and methicillin. 
 These results were the first to demonstrate the antibacterial activity of Cymbopogon citratus essential oil against 
MRSA strains and nosocomial bacterial. 
 In recent years several screenings of medicinal plants used for the treatment of bacterial infections have been carried 
out, demonstrating the chromatographic fraction of the essential oil of Cymbopogon citratus in agar plate was active on 
Bacillus subtilis, Escherichia coli, Staphylococus aureus[15-16] and Salmonella paratyphi and Shigella flexneri [17] 
confirming the importance of many plant species and essential oils as potential sources for the isolation of novel 
compounds with antibacterial effect. These activities are shown in two of the three main components of the oil 
identified through chromatographic and mass spectrometric methods. While the α-citral (geranial) and β-citral (neral) 
compounds individually elicit an antibacterial action on gram-negative and gram-positive organisms, the third 
component, myrcene, did not show any observable antibacterial activity on its own [18]. The extract was also active 
when the volatile oil extract was oxidized via the active oxygen method [19–22]. 
 A common feature of plant volatiles is their hydrophobic nature, and several studies addressing the mode of action of 
such compounds usually point at cell membranes as the primary target [23]. In our study we observed an increase in cell 
permeability measure by ethidium bromide entry to the cells. In this sense, we hypothesized that essential oil and citral 
may have a passive entry and may accumulate in bacterial cell membranes leading to an increased permeabilization, and 
pore formation. Other authors refered conclude similar to our work. The interaction affects membrane permeability, and 
this has been documented by loss of membrane potential, cellular uptake of ethidium bromide, and leakage of potassium 
ions, ATP, and carboxyfluorescein [24-27]. 
3. Conclusions 
Briefly, it can be concluded that in this study, we found that the essential oil of Cymbopogon citratus has in is 
composition phenolic compounds, alcohols and terpenes. It was demonstrated that the antibacterial properties of the 
essential oil of Cymbopogon citratus may be attributed to citral (mixture of the two isomers geranial and neral). 
 The essential oil of Cymbopogon citratus revealed a strong antibacterial activity on Staphylococcus aureus and 
Staphylooccus epidermidis when compared to augmentim and antibiotics such as penicillin and methicillin. This has 
been observed in strains of reference, and enhanced effect in multidrug-resistant strains. 
 The antibacterial effect of the major compounds contributes to the final antibacterial effect of essential oil, since 
individually these compounds exhibit antibacterial effects smaller than essential oil. It was impossible to assign to a 
compound the antibacterial activity of the essential oil. All constituents tested were cytotoxic for various bacterial 
strains tested, but revealed less antibacterial effect than the essential oil, suggesting that other minor constituents 
contribute to overall antibacterial activity. 
 The determination of the minimum inhibitory concentration, which identified the bactericide effect, occurs at 
concentrations above 0.920 mM for strain S. aureus and 1.840 mM for strains of E. Coli and S. epidermidis. 
This study proved the essential oil of Cymbopogon citratus has antibacterial activity, and as such being an option for 
obtaining natural antibiotics and the development of new pharmacologically active molecules against multi-resistant 
strains. 
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